| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |